BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

  TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2023, along with recent company developments.

  November 1, 2023

   · 

  19 min read
• BioMidwest

  Inspire Medical Systems, Inc. to Present at the Stifel 2023 Healthcare Conference

  Inspire Medical Systems, Inc. announced that its management team will present at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023.

  November 1, 2023

   · 

  1 min read
• Business

  BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023

  BrainsWay Ltd. announced that it will report its third quarter 2023 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, November 15, 2023.

  November 1, 2023

   · 

  2 min read
• Business

  Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer

  Spero Therapeutics, Inc. announced the appointment of Esther Rajavelu as Chief Financial Officer and Chief Business Officer.

  November 1, 2023

   · 

  7 min read
• BioMidwest

  Inotiv, Inc. to Participate in Upcoming November 2023 Investor Conferences

  Inotiv, Inc. announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in multiple upcoming investor conferences throughout November 2023.

  November 1, 2023

   · 

  1 min read
• Pharm Country

  Tourmaline Bio to Present at Upcoming November 2023 Investor Conferences

  Tourmaline Bio, Inc. announced that Sandeep Kulkarni, CEO, will participate in the following investor conferences in November:

  November 1, 2023

   · 

  1 min read
• Business

  Corcept Appoints Monica Tellado as President, Emerging Markets

  Corcept Therapeutics Incorporated announced the appointment of Monica Tellado as President, Emerging Markets.

  November 1, 2023

   · 

  3 min read
• Business

  MBX Biosciences Announces Appointment of Michelle Graham as Chief Human Resources Officer

  MBX Biosciences, Inc. announced the appointment of Michelle Graham as Chief Human Resources Officer.

  November 1, 2023

   · 

  2 min read
• Genetown

  Merus to Participate in Upcoming November 2023 Investor Conferences

  Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in the following investor conferences.

  November 1, 2023

   · 

  1 min read
• Biotech Beach

  aTyr Pharma to Present at November 2023 Investor Conferences

  aTyr Pharma, Inc. announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present at two upcoming investor conferences scheduled to take place in November 2023.

  November 1, 2023

   · 

  1 min read